TJP_LABS_Logo.png
TJP Labs Inc. Amends Its Drug Establishment License and Achieves Approval for Active Pharmaceutical Ingredients
November 17, 2022 15:04 ET | TJP Labs Inc.
PICKERING, Ontario, Nov. 17, 2022 (GLOBE NEWSWIRE) -- TJP Labs Inc. ("TJP Labs") is North America's leading full-service contract manufacturer of premier next-generation products, focusing on modern...
Pure Extracts Logo.jpg
Pure Extracts Receives Approval from Manitoba Liquor & Lotteries to list Pure Pulls Vapes and Pure Chews Edibles
November 16, 2022 08:45 ET | Pure Extracts Technologies Corp.
VANCOUVER, British Columbia, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction...
OptimiTM-03.jpg
Optimi Health, ATMA Journey Centers To Proceed With Phase I Natural Psilocybin and MDMA Clinical Trial Application to Health Canada
September 22, 2022 09:00 ET | Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health...
Lift & Co LOGO.jpg
Lift&Co. Expo Cannabis Conference & Trade Show Returns to Vancouver with New Vision, New Elements & Unique Experience for All
September 20, 2022 09:35 ET | Lift&Co. Expo
VANCOUVER, British Columbia, Sept. 20, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Following a three-year hiatus, Lift&Co. Expo will return to Vancouver Convention Centre on January 12-14,...
Arcutis logo.png
Arcutis Biotherapeutics Announces Health Canada Accepts for Review the New Drug Submission for Roflumilast Cream for Adults and Adolescents with Plaque Psoriasis
July 11, 2022 08:00 ET | Arcutis Biotherapeutics, Inc.
Submission supported by positive clinical data from the pivotal Phase 3 DERMIS-1 and DERMIS-2 clinical studies, as well as results from long-term safety studiesIf approved, roflumilast cream would be...
Pure Extracts Logo.jpg
Pure Extracts Signs Listing Agreement with Shoppers Drug Mart and Receives Initial Purchase Order
June 30, 2022 08:45 ET | Pure Extracts Technologies Corp.
VANCOUVER, British Columbia, June 30, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction...
Optimi Health Requests Approval To Manufacture MDMA, Other Synthetic Psychedelics
June 20, 2022 09:00 ET | Optimi Health Corp.
VANCOUVER, British Columbia, June 20, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
Infant Formula Producers Facing Crisis Can Rely on Southern California ProTab Labs for Safe Rapid Large-Scale Production of Premixes and Packaging Solutions
June 16, 2022 09:00 ET | ProTab Laboratories
Foothill Ranch, Calif., June 16, 2022 (GLOBE NEWSWIRE) -- To tackle the infant formula crisis, producers can rely on Southern California supplement solutions contract manufacturer ProTab...
Isracann BioSciences Logo RGB@4x-100 LG.jpg
Isracann Biosciences Subsidiary Praesidio Health Submits NPNs to Health Canada
May 19, 2022 08:30 ET | Isracann Biosciences Inc.
VANCOUVER, British Columbia, May 19, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted organization with a natural health...
Optimi Health Granted Amendment To Controlled Substances Dealer’s Licence
May 04, 2022 09:00 ET | Optimi Health Corp.
VANCOUVER, British Columbia, May 04, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that a requested Amendment...